FdaApplication
NDA 020177
Identifiers
- fda_app_no: NDA020177
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 1995-10-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER | AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE | 3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100ML | INJECTABLE;INJECTION |
1 product